Knowledge concerning the biological effects in man of small body burdens of radioactive material is limited, and is virtually confined to studies on persons, such as luminizers, who have ingested radium, or patients who have received Thorotrast during clinical investigation in the past. Thorotrast, a colloidal suspension of 232 thorium dioxide, was extensively used as a radiographic contrast medium between 1930 and 1947 when its use was largely abandoned following the report of the first malignancy attributable to this compound (MacMahon, Murphy, and Bates, 1947) .
Many investigators have been concerned in assessing the risk of the development of malignant disease in internally irradiated populations. For example, it is now known that an increased incidence of osteogenic sarcoma is associated with body burdens of radium in excess of 0 4 ,tc. (Dunham, 1958) and haemangioendothelioma of the liver is virtually a Thorotrast-specific tumour (Horta, Abbatt, da Motta, and Roriz, 1965) . In contrast, there is little or no information concerning the incidence of diseases, other than malignancies, in populations exposed to internal radiation. A In 1963, following an attack resembling angina pectoris, the patient was treated with digoxin and potassium iodide. In June 1964 he was admitted to hospital complaining of increasing breathlessness, nausea, and abdominal discomfort, and was found to have a spontaneous pneumothorax. In addition, there was atrial fibrillation. The isthmus of the thyroid gland was enlarged.
Tests for thyroid antibodies were negative. The uptake of '31I at four hours was 65 %. The T3 absorption test was in the hyperthyroid range. Liver function tests showed a consistent reversal of the A/G ratio (albumin 3-2 g. %, globulin 3-1 g. %). Alkaline phosphatase was 24 K.A. units, S.G.O.T. 29 units, S.G.P.T. 23 units.
The patient was treated with 6 mc. of 1311 and carbimazole and is now euthyroid. CASE 2 J.S., a man aged 44, at the age of 18 had a spontaneous subarachnoid haemorrhage which produced a right hemiparesis. The The left hemiparesis persists. Epilepsy is controlled by phenobarbitone. She is euthyroid.
The main features of these cases are summarized in Table 1 . DISCUSSION We have been unable to obtain figures for the incidence of thyroid disease in Scotland. Logan and Cushion (1958) have reported the incidence of thyrotoxicosis in England and Wales to be 0 3 and 1-9 per 1,000 for males and females respectively. If one assumes that the corresponding figures for Scotland do not differ significantly from those given by Logan and Cushion the incidence of thyrotoxicosis in our cases is some 16 times greater than expected in males (P< 0-005), and some two and a half times greater in females.
There are several features common to the four cases developing thyrotoxicosis. Each suffered a spontaneous subarachnoid haemorrhage, in the course of investigation of which angiography, using Thorotrast, was carried out. No cause for the haemorrhage was demonstrated in two cases and no definitive treatment was undertaken. In the remaining two cases the haemorrhage occurred from an arterial aneurysm which was dealt with surgically.
Angiography, using Thorotrast, was carried out in a fifth patient who subsequently developed non-toxic thyroid enlargement. Although there is no definite history of subarachnoid haemorrhage in this patient an arteriovenous malformation was demonstrated, and was subsequently treated by x-ray therapy.
On the basis of four cases, and without fuller investigation, it is not possible to say whether the cases of thyrotoxicosis which developed in this series are aetiologically distinct, although an ratio is in contrast to that normally found in large series where the incidence in females is some six times greater than in males (Logan and Cushion, 1958) .
In the majority of cases of thyrotoxicosis occurring in this country, the gland shows diffuse hyperplasia. The cases which we are reporting did not differ in this respect. The gland was diffusely enlarged in three patients, two of whom had either exophthalmos or lid retraction. In the fourth patient, who presented with thyrotoxic heart disease, only the thyroid isthmus was palpably enlarged.
In common with the remaining cases in the series the patients who developed thyrotoxicosis had characteristic changes in the peripheral blood, consisting of a disturbance of red cell morphology and the presence of Howell-Jolly bodies in erythrocytes. These have been reported in detail by Langlands and Williamson (1967) who concluded that, as a result of radiation by the particles of thorium retained in reticulo-endothelial cells, there was a considerable disturbance of splenic function amounting to atrophy of that organ. Schur (1908) has also recorded the association of thyrotoxicosis and the presence of Howell-Jolly bodies in the erythrocytes of a patient in whom splenic atrophy was found at post-mortem examination.
More usually thyrotoxicosis is associated with splenomegaly, and, according to Williams (1962) (McKenzie, 1962) .
In the cases which we report, following Thorotrast administration, the evidence for splenic atrophy is indirect and is inferred from peripheral blood changes. Thorotrast is retained by lymphoreticular cells and the possibility of abnormal function of these cells, as opposed to simple loss of function, is worth investigation.
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ADDENDUM
Since submission of the manuscript a further case of thyroid disease following Thorotrast administration has been seen in a woman of 55. In 1947, at the age of 35, she suffered a spontaneous subarachnoid haemorrhage, the diagnosis being confirmed by lumbar puncture. No source of bleeding was demonstrated following bilateral carotid angiography when 32 ml. of Thorotrast was injected. In 1953, during investigation in hospital for an iron-deficiency anaemia, asymptomatic enlargement of the thyroid gland was noted. When seen in 1967 the thyroid gland remained moderately enlarged, the enlargement affecting mainly the right lobe. Clinically she was euthyroid. The level of protein-bound iodine was 4 3 yg/lOO ml. 1311 uptake was normal at four hours.
